1. Home
  2. MTSI vs RGEN Comparison

MTSI vs RGEN Comparison

Compare MTSI & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MTSI
  • RGEN
  • Stock Information
  • Founded
  • MTSI 1950
  • RGEN 1981
  • Country
  • MTSI United States
  • RGEN United States
  • Employees
  • MTSI N/A
  • RGEN N/A
  • Industry
  • MTSI Semiconductors
  • RGEN Medical/Dental Instruments
  • Sector
  • MTSI Technology
  • RGEN Health Care
  • Exchange
  • MTSI Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • MTSI 9.2B
  • RGEN 8.0B
  • IPO Year
  • MTSI 2012
  • RGEN N/A
  • Fundamental
  • Price
  • MTSI $136.16
  • RGEN $131.04
  • Analyst Decision
  • MTSI Strong Buy
  • RGEN Buy
  • Analyst Count
  • MTSI 9
  • RGEN 11
  • Target Price
  • MTSI $136.56
  • RGEN $169.33
  • AVG Volume (30 Days)
  • MTSI 702.9K
  • RGEN 677.5K
  • Earning Date
  • MTSI 07-31-2025
  • RGEN 07-29-2025
  • Dividend Yield
  • MTSI N/A
  • RGEN N/A
  • EPS Growth
  • MTSI N/A
  • RGEN N/A
  • EPS
  • MTSI N/A
  • RGEN N/A
  • Revenue
  • MTSI $845,205,000.00
  • RGEN $650,429,000.00
  • Revenue This Year
  • MTSI $33.87
  • RGEN $13.93
  • Revenue Next Year
  • MTSI $12.63
  • RGEN $14.35
  • P/E Ratio
  • MTSI N/A
  • RGEN N/A
  • Revenue Growth
  • MTSI 32.63
  • RGEN 4.88
  • 52 Week Low
  • MTSI $84.00
  • RGEN $102.97
  • 52 Week High
  • MTSI $152.50
  • RGEN $182.52
  • Technical
  • Relative Strength Index (RSI)
  • MTSI 53.66
  • RGEN 57.17
  • Support Level
  • MTSI $135.16
  • RGEN $123.34
  • Resistance Level
  • MTSI $141.75
  • RGEN $129.11
  • Average True Range (ATR)
  • MTSI 3.66
  • RGEN 4.31
  • MACD
  • MTSI -1.02
  • RGEN 1.06
  • Stochastic Oscillator
  • MTSI 24.58
  • RGEN 77.06

About MTSI MACOM Technology Solutions Holdings Inc.

MACOM Technology Solutions Holdings Inc is a provider of analog, digital, and mixed-signal semiconductor solutions to original equipment manufacturers and distributors. These solutions are found in systems for industrial, medical, scientific, and test and measurement markets. The firm's portfolio of products includes integrated circuits, multichip modules, power pallets and transistors, diodes, amplifiers, switches and switch limiters, passive and active components, and complete subsystems. Roughly a third of the firm's revenue is generated in the United States, with the rest coming from China, Japan, Singapore, South Korea, and other countries across the world.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: